In the direct-to-consumer market, however, this approach pits two value propositions against each other: helping patients build habits that allow them to discontinue GLP-1s versus encouraging long-term use through maintenance dosing
[17] [18] Your healthcare team can assess whether dose adjustment, additional supportive treatments, or switching to a different medication class would be more appropriate for your circumstances
Given that semaglutide works to reduce a patients blood sugar (glycaemia), the authors concluded semaglutide-related NAION may be a consequence of glycaemia reduction and not an off-target effect. It was recommended that a base-line eye examination be conducted prior to the start of semaglutide to identity patients who may be at risk of developing NAION
[DOI] [PubMed] [Google Scholar] 33.Lutsenko S, Bhattacharjee A, Hubbard AL
In: Enrquez, P
According to their website, programs may cost between $170 to $554 for the first month